Seattle Children's Research Institute

Seattle Children's Research Institute, the research division of Seattle Children's, was established in 2006. The research institute's campus encompasses 310,000 square feet (29,000 m) in three buildings in downtown Seattle. The research institute has 588 staff members, including 249 principal investigators focusing on infectious disease, cancer, immunology and many other areas.

Website
http://www.seattlechildrens.org/
Wikipedia
http://en.wikipedia.org/wiki/Seattle_Children%27s_Research_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Oncology & Cancer

Study helps parents build resilience to navigate child's cancer

Tatum Fettig remembers when her family's lives changed forever. In 2016, her daughter Teagan began vomiting and struggling with balance. At Seattle Children's, Teagan, then 2, was diagnosed with a pediatric brain tumor, medulloblastoma. ...

Immunology

Researchers ready B cells for novel cell therapy

Scientists at Seattle Children's Research Institute are paving the way to use gene-edited B cells—a type of white blood cell in the immune system—to treat a wide range of potential diseases that affect children, including ...

Immunology

Secret to sepsis may lie in rare cell

In a paper published in Nature Immunology, scientists from Seattle Children's Research Institute reveal how a rare group of white blood cells called basophils play an important role in the immune response to a bacterial infection, ...

Neuroscience

New findings on concussion in football's youngest players

New research from Seattle Children's Research Institute and UW Medicine's Sports Health and Safety Institute found concussion rates among football players ages 5-14 were higher than previously reported, with five out of every ...

Oncology & Cancer

Solid tumors targeted in new CAR T-Cell immunotherapy trial

Seattle Children's has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system EGFR-expressing solid tumors. In the phase 1 ...

Diabetes

Immunotherapy, gene editing advances extend to Type 1 Diabetes

Advances in engineering T cells to treat cancer are paving the way for new immunotherapies targeted at autoimmune diseases, including type 1 diabetes. Now, researchers are also investigating therapies that reprogram T cells ...

page 1 from 3